Display options
Share it on

J Thorac Dis. 2016 Jun;8(6):1179-87. doi: 10.21037/jtd.2016.04.51.

Noninferiority of Shanghai Cingular biotech's bovine pericardial valve preclinical study in juvenile ovine model.

Journal of thoracic disease

Jin-Miao Chen, Yu Ding, Shu-Yang Lu, Sun Pan, Mieradilijiang Abudupataer, Tao Hong, Chun-Sheng Wang

Affiliations

  1. Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

PMID: 27293835 PMCID: PMC4885996 DOI: 10.21037/jtd.2016.04.51

Abstract

BACKGROUND: This study introduces a newly Chinese domestic-designed/manufactured bovine pericardial valve, the SCBC valve (Shanghai Cingular Biotech Corporation, Shanghai, China), and evaluates its hemodynamic performance and calcification potential compared with the Carpentier-Edwards (CE) Perimount(TM) valve (Edwards Lifesciences, Irvine, CA, USA) in juvenile sheep for preclinical study.

METHODS: Five SCBC valves in study group and three CE Perimount(TM) valves (6900P with TFX) in control group were implanted in the mitral position of juvenile sheep and followed up for five months. Transthoracic echocardiography (TTE) for hemodynamic measurement was performed ten days, three months and five months postoperatively. Valve calcification was assessed by X-ray after euthanasia. Other collected data included macroscopic examination, blood analysis, microorganism culture and histological assessment.

RESULTS: All sheep in two groups lived to sacrifice without evidence of valvular dysfunction. The SCBC valve had similar hemodynamic performance and susceptibility of calcification compared with the CE Perimount(TM) valve in juvenile ovine model. In all other parameters, the SCBC valve also exhibited no significant difference compared with the CE Perimount(TM) valve.

CONCLUSIONS: Our study demonstrated that the SCBC valve can exhibit similar mid-term satisfactory safety and efficacy compared with the CE Perimount(TM) valve in the mitral position of juvenile sheep model.

Keywords: Carpentier-Edwards PerimountTM valve; SCBC valve; bovine pericardial valve; noninferiority

References

  1. J Thorac Cardiovasc Surg. 2006 Jul;132(1):89-98 - PubMed
  2. Eur J Pharmacol. 2015 Jul 15;759:192-9 - PubMed
  3. J Am Coll Cardiol. 2010 Jun 1;55(22):2413-26 - PubMed
  4. J Thorac Cardiovasc Surg. 2014 Dec;148(6):3194-201 - PubMed
  5. J Thorac Cardiovasc Surg. 2009 Jan;137(1):82-90 - PubMed
  6. Circulation. 1999 Nov 9;100(19 Suppl):II11-6 - PubMed
  7. Thorac Cardiovasc Surg. 1983 Oct;31(5):288-90 - PubMed
  8. Heart Surg Forum. 2011 Jun;14(3):E160-5 - PubMed
  9. Ann Thorac Cardiovasc Surg. 2004 Feb;10(1):23-8 - PubMed
  10. Ann Thorac Surg. 2010 May;89(5):1410-6 - PubMed
  11. ASAIO J. 2003 Jul-Aug;49(4):454-8 - PubMed
  12. Heart. 2007 May;93(5):639-44 - PubMed
  13. J Am Coll Cardiol. 2015 Nov 3;66(18):2019-37 - PubMed
  14. J Heart Valve Dis. 2006 Nov;15(6):768-75; discussion 775-6 - PubMed
  15. Ann Thorac Surg. 2013 Aug;96(2):486-93 - PubMed
  16. Ann Thorac Surg. 2010 Sep;90(3):775-81 - PubMed
  17. Am J Pathol. 1982 Jan;106(1):136-9 - PubMed
  18. J Thorac Cardiovasc Surg. 1983 Jul;86(1):115-25 - PubMed
  19. J Heart Valve Dis. 1998 Jul;7(4):419-27 - PubMed

Publication Types